Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
BlueYard Capital
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…
Slate MedicinesSeries A $130M · 7 mo ago • Founded 2024 • 51-200 employees
We’re building a pipeline of next-generation therapeutics focused on broadening the treatment paradigm for migraine and other headache…
Damona Pharmaceuticals201-500 employees
Damona Pharmaceuticals is developing precision neuromedicines to reverse cognitive deficits associated with brain disorders.associated with…
Lario TherapeuticsFounded 2021 • 11-50 employees
Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience…
BexorgFounded 2021 • 3 roles
Technology About us Careers News and Events Contact us About us ( xo ) From groundbreaking neuroscience begins a transformative future…
Pangea Bio11-50 employees
Developing transformative medicines for neurological and mental health disorders.

Overview

Biomia rationally engineers nature-inspired novel small molecule therapeutics to treat CNS disorders.

News

News FinanzNachrichten.de 8 months ago
IRLAB Therapeutics: IRLAB Enters Collaboration Agreement with Danish Biotech Company Biomia ApS Applying the Integrative Screening Process
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, SE / ACCESS Newswire / January 19, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company
Read more
Report
News Nature Index 1 year ago
Biomia ApS
Research outputs, collaborations and relationships for Biomia ApS
Read more
Report
News Nature 3 years ago
Biosynthesis of natural and halogenated plant monoterpene indole alkaloids in yeast
Monoterpenoid indole alkaloids (MIAs) represent a large class of plant natural products with marketed pharmaceutical activities against a wide range of indications, including cancer, malaria and hypertension. Halogenated MIAs have shown improved pharmaceu
Read more
Report
News Nature 4 years ago
A microbial supply chain for production of the anti-cancer drug vinblastine
Monoterpene indole alkaloids (MIAs) are a diverse family of complex plant secondary metabolites with many medicinal properties, including the essential anti-cancer therapeutics vinblastine and vincristine1. As MIAs are difficult to chemically synthesize,
Read more
Report
News Nature 6 years ago
Combining mechanistic and machine learning models for predictive engineering and optimization of tryptophan metabolism
Through advanced mechanistic modeling and the generation of large high-quality datasets, machine learning is becoming an integral part of understanding and engineering living systems. Here we show that mechanistic and machine learning models can be combin
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.